Divalproex Sodium Tablet, Delayed Release
Product Images NDC 60760-798

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 60760-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

798-60 (Divalproex 60760 798 60)

This is information related to a medication called Divalproex Sodium in the form of 500mg delayed-release tablets. The tablets contain Valproic Acid and are used for the treatment of certain conditions. The medication is labeled with NDC 60760-798-60 and various lot numbers. It is manufactured by Sun Pharmaceutical Industries Ltd in India and packaged by a pharmacy program. The prescription should be taken as directed and stored at a controlled room temperature between 15°C to 30°C (59°F to 86°F).*

FDA Label Image

Spl-divalproex-figure-1 (Spl Divalproex Figure 1)

FDA Label Image

Spl-divalproex-figure-2 (Spl Divalproex Figure 2)

This document appears to be a chart or graph displaying the percentage of patients showing improvement, no change, or worsening with the use of DVPX compared to a placebo. It also includes specific percentage figures depicting reductions or increases in CPS rate. The graph seems to illustrate different outcomes in a clinical trial or study involving the use of DVPX and a placebo.*

FDA Label Image

Spl-divalproex-figure-3 (Spl Divalproex Figure 3)

FDA Label Image

Spl-divalproex-figure-4 (Spl Divalproex Figure 4)

This text provides data on the mean 4-week migraine rates for a placebo and DVPX treatment in Study 1 and Study 2. It presents information on the comparison between the two treatments to evaluate their effectiveness in managing migraines.*

FDA Label Image

Spl-divalproex-structure (Spl Divalproex Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.